<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8606714</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4754</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Child Neurol.</journal-id>
<journal-title-group>
<journal-title>Journal of child neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28393671</article-id>
<article-id pub-id-type="pmc">5502756</article-id>
<article-id pub-id-type="doi">10.1177/0883073817701368</article-id>
<article-id pub-id-type="manuscript">HHSPA873867</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Secondary conditions among males with Duchenne or Becker muscular dystrophy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Latimer</surname>
<given-names>Rebecca</given-names>
</name>
<degrees>MMSc</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Street</surname>
<given-names>Natalie</given-names>
</name>
<degrees>MS</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Conway</surname>
<given-names>Kristin Caspers</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>James</surname>
<given-names>Kathy</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cunniff</surname>
<given-names>Christopher</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oleszek</surname>
<given-names>Joyce</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fox</surname>
<given-names>Deborah</given-names>
</name>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ciafaloni</surname>
<given-names>Emma</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Westfield</surname>
<given-names>Christina</given-names>
</name>
<degrees>BSN</degrees>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paramsothy</surname>
<given-names>Pangaja</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<collab>the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STAR<italic>net</italic>)</collab>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Cardiogenetic Testing Services, GeneDx, Gaithersburg, MD</aff>
<aff id="A2">
<label>2</label>Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA</aff>
<aff id="A3">
<label>3</label>Department of Epidemiology, College of Public Health, The University of Iowa, Iowa City, IA</aff>
<aff id="A4">
<label>4</label>University of Colorado, Denver, Aurora, CO</aff>
<aff id="A5">
<label>5</label>Department of Pediatrics, Weill Cornell Medical College, New York, NY</aff>
<aff id="A6">
<label>6</label>Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, Children’s Hospital Colorado, Aurora, CO</aff>
<aff id="A7">
<label>7</label>New York State Department of Health, Albany, NY</aff>
<aff id="A8">
<label>8</label>University of Rochester Medical Center, Rochester, NY</aff>
<author-notes>
<corresp id="FN1"><bold>Corresponding author</bold>: Natalie Street, MS, 4770 Buford Hwy, MS E-88, Atlanta, GA 30341-3717, <email>ntl2@cdc.gov</email>, Phone: (404) 498-3001, Fax: (770) 488-0270</corresp>
<fn fn-type="COI-statement" id="FN4">
<p id="P29">
<bold>Declaration of Conflicting Interests</bold>
</p>
<p id="P30">The authors declare that there are no conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>32</volume>
<issue>7</issue>
<fpage>663</fpage>
<lpage>670</lpage>
<!--elocation-id from pubmed: 10.1177/0883073817701368-->
<abstract>
<p id="P1">Duchenne and Becker muscular dystrophy are X-linked neuromuscular disorders characterized by progressive muscle degeneration. Despite the involvement of multiple systems, secondary conditions among affected males have not been comprehensively described. Two hundred and nine caregivers of affected males (aged 3–31 years) identified by the Muscular Dystrophy Surveillance, Tracking, and Research Network completed a mailed survey that included questions about secondary conditions impacting multiple body functions. The five most commonly reported conditions in males with Duchenne were cognitive deficits (38.4%), constipation (31.7%), anxiety (29.3%), depression (27.4%), and obesity (19.5%). Higher frequencies of anxiety, depression, and kidney stones, were found among non-ambulatory males compared to ambulatory males. Attention deficit hyperactivity disorder was more common in ambulatory than non-ambulatory males. These data support clinical care recommendations for monitoring of patients with Duchenne or Becker muscular dystrophy by a multidisciplinary team to prevent and treat conditions that may be secondary to the diagnosis.</p>
</abstract>
<kwd-group>
<kwd>Duchenne</kwd>
<kwd>Becker</kwd>
<kwd>muscular dystrophy</kwd>
<kwd>secondary conditions</kwd>
<kwd>co-morbidities</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>